Innervation of melanocytes in human skin by unknown
Innervation of Melanocytes in Human Skin 
By Masahiro  Hara,* Masahiko Toyoda,* MinaYaar,* Jag Bhawan,~ 
Elena M. Avila,* Ian R. Penner,*  and Barbara A. Gilchrest* 
From the *Department of Dermatology and ~-Dermatopathology Section, Boston University School of 
Medicine, Boston, Massachusetts 02118-2394 
Summary 
Communication between the  nervous system and epidermal melanocytes has been suspected 
on the basis of their common embryologic origin and apparent parallel involvement in several 
disease processes, but never proven. In this study, confocal microscopic analysis  of human skin 
sections stained with antibodies specific for melanocytes and nerve fibers showed intraepider- 
real nerve endings in contact with melanocytes. This intimate contact was confirmed by elec- 
tron microscopy, which further demonstrated thickening of apposing plasma membranes be- 
tween melanocytes and nerve fibers, similar to synaptic contacts seen in nervous tissue.  Since 
many intraepidermal  nerve  fibers  are  afferent nerves  that  act  in  a  "neurosecretory"  fashion 
through  their terminals,  cultured human melanocytes were stimulated with calcitonin  gene- 
related peptide (CGRP), substance P, or vasoactive intestinal peptide, neuropeptides known to 
be present in cutaneous nerves, to examine their possible functions in the epidermal melanin 
unit. CGRP increased DNA synthesis rate ofmelanocytes in a concentration- and time-depen- 
dent manner.  Cell yields after 5 d were increased 25% compared with controls maintained in 
an otherwise optimized medium. Furthermore, stimulation by CGRP induced rapid and dose- 
dependent  accumulation of intracellular cAMP, suggesting that the mitogenic effect is medi- 
ated by the cAMP pathway. These studies confirm and expand a single earlier report in an ani- 
mal model of physical contact between melanocytes and cutaneous nerves and for the first time 
strongly suggest that the nervous system may exert a tonic effect on melanocytes in normal or 
diseased human skin (Mihara, K., K. Hashimoto, and M. Kumakiri. 1982. J.  Dermatol.  19:1-43). 
I 
nteractions  between  the  nervous  system and  cutaneous 
melanocytes have long been speculated  on the  basis  of 
embryologic  and  phylogenic  features  of  melanocytes  as 
well as on several forms of clinical evidence. Embryologi- 
cally, both melanocytes and peripheral nervous system neu- 
rons originate from the neural crest (1). In lower vertebrate 
species,  movement of melanosomes within  pigment  cells 
leading to color change in the skin is directly regulated by 
autonomic nerves (2).  In patients with tuberculoid leprosy, 
it is known that depigmentation  and anesthesia  coexist in 
the innervation area of the affected peripheral nerves (3).  It 
has also been noted that skin color is normalized only after 
reinnervation of treated areas when hyperpigmented skin is 
dermabraded  (4),  a  procedure  expected  to  destroy  many 
superficial nerve endings,  and that degeneration  of nerves 
occurs in segmental vitiligo lesions corresponding in loca- 
tion  to  the  area  of distribution  of the  local  nerve,  and 
regenerating nerves are subsequently observed during a course 
of  therapy  leading  to  repigmentation  (5).  Degenerative 
changes  or increased  subepidermal  nerves  have  also  been 
reported in other dyschromatic skin lesion (6). 
Furthermore,  increased  numbers  of nerve  fibers  have 
been found in benign melanocytic skin lesions such as ac- 
quired and congenital nevi (7).  In contrast, in primary ma- 
lignant melanoma lesions the number of nerve fibers is de- 
creased in proportion  to  tumor thickness,  suggesting that 
normal melanocytes produce neurite promoting factors. In 
addition, close association ofmelanocytes with nerve fibers 
containing calcitonin gene-related peptide  (CGRPp,  sub- 
stance P (SP), and neuropeptide Y has been reported through- 
out  all  regions  of the  uvea  (8-10),  although  their role  in 
ophthalmic melanocyte biology is not known. 
Finally,  Mihara  and  co-workers  (11)  reported  a  direct 
contact, similar to synaptic contacts in the nervous system, 
between  cutaneous  nerve endings  and epidermal melano- 
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confirmed  and  such  contacts  were  never  reported  in  hu- 
man skin. 
Skin  is  innervated  primarily  by  sensory  nerves  and  by 
postganglionic parasympathetic and sympathetic nerves. Sen- 
sory nerves have been shown to function not only as an af- 
ferent system to conduct stimuli from the skin to the cen- 
tral nervous system, but also as efferent system to stimulate 
target  tissue  by  secreting  several  kinds  of neuropeptides 
(NPs)  through  their  branches  (12).  It is  well  known  that 
some inflammatory skin  disorders,  including psoriasis  and 
atopic  dermatitis,  characteristically  worsen  with  anxiety 
(13,  14).  Urticaria  may also be  triggered by tension  (15). 
These interactions between psychic state and expression of 
skin disorders are possibly attributable to NP secretion from 
sensory nerves,  in that many NPs are able  to provoke in- 
flammatory  reactions  (16).  CGtLP  induces  characteristic 
long-lasting  erythema  when  injected  intradermally  (17). 
vasoactive  intestinal  polypeptide  (VIP)  and  peptide-histi- 
dine  isoleucine  similarly  stimulate  vasodilatation  (18);  and 
VIP,  SP,  neurotensin,  and  somatostatin  degranulate  mast 
cells  (19).  Mternatively,  NPs may modulate  inflammatory 
conditions  indirectly  through  regulating  the  immune  sys- 
tem  (20).  SP enhances proliferation and function of T  and 
B  cells and stimulates  IL-1 and IL-6 production by T  cells 
(21,  22).  VIP  inhibits  T  cell  proliferation  and  migration 
(23,  24).  Furthermore,  CGgP-containing nerves were re- 
cently  reported  to  make  close  contact  with  epidermal 
Langerhans cells and, at least in vitro, CGRP was shown to 
inhibit  their antigen-presenting function  (25).  In addition, 
the  involvement of the  nervous system in pathologic skin 
reactions  strongly  suggests  that  the  nervous  system  may 
participate  in maintenance  of the physiological integrity of 
the  skin.  Indeed,  SP-containing  nerve  fibers  are  regener- 
ated  during  the  early  healing  stage  of burn  wounds  in 
guinea pig skin (26), and SP promotes proliferation of arte- 
rial smooth muscle cells and skin fibroblasts (27). VIP is mi- 
togenic for human keratinocytes  (28,  29),  and  CGRP  in- 
duces proliferation of endothelial cells  (30). 
Neurotrophic effects of NPs are also reported in the ner- 
vous  tissue.  Some  NPs,  including  CGRP,  are  normally 
made by both sensory nerves in dorsal root ganglia and by 
motor neurons;  interestingly,  CGRP  synthesis  is increased 
after nerve injury (31-33),  suggesting that this peptide may 
play a role in nerve regeneration.  Indeed, CGRP promotes 
Schwann cell proliferation through activating cAMP path- 
ways (34). Because Schwann cells and melanocytes are both 
of neural crest origin, it is plausible that melanocyte behav- 
ior is also regulated by NPs. 
In this  study, we show that melanocytes in human skin 
connect to intraepidermal  nerve  terminals  via synapse like 
structures.  Furthermore,  CGRP, a neuropeptide known to 
exist  in  intraepidermal  nerve  terminals,  upregulates  DNA 
synthesis and proliferation  of melanocytes through activat- 
ing cAMP pathways. These results suggest an intimate rela- 
tionship  between  the  nervous  system and  epidermal  mel- 
anocytes  of probable  relevance  to  normal  and  pathologic 
pigmentation in the skin. 
Materials  and Methods 
Human Melanocyte Isolation and Culture.  Neonatal foreskins ob- 
tained  within 24 h of elective  circumcision were used to culture 
human melanocytes as previously described  (35). In brief, the epi- 
demlis was separated  from the dermis  after overnight incubation 
in 0.25% trypsin at 4~  Primary cultures were then established in 
medium  199  (GIBCO BRL,  Grand  Island,  NY)  supplemented 
with  10  ng/ml  epidermanl  growth  factor  (Bethesda  Research 
Laboratories, Gaithersburg,  MD), 10 -~) M triiodothyronine (Sigma 
Chemical  Co.,  St.  Louis,  MO),  10  I*g/ml  transferrin  (Sigma), 
10 ~g/ml insulin  (Sigma), 1.4 ￿  10 -~ M hydrocortisone (Calbio- 
chem-Behring Corp., La Jolla,  CA),  10 -v M  cholera toxin  (List 
Biological  Laboratories,  Inc.,  Campbell,  CA),10 ng/ml basic fi- 
broblast  growth  factor  (bFGF)  (Amgen  Biologicals,  Thousand 
Oaks,  CA), and 5-10% fetal bovine serum.  Post-primary cultures 
were maintained in a low calcium (0.03 mM) version of this de- 
fined  melanocyte growth medium known to selectively  support 
melanocyte growth (36). In experiments examining the effect of 
CGRP  and bFGF  on melanocyte yield,  primary cultures  were 
maintained  in  the  same  medium  but,  instead  of cholera  toxin, 
cells were supplemented  with 10 -4 M  dibuwryl cAMP (dbcAMP) 
(Sigma)  and  0.6  ug/ml  bovine  pituitary  extract  (Collaborative 
Biomedical  Products,  Lincoln  Park,  NJ).  Post-primary cultures 
were maintained in low calcium (0.03 raM) version  of this me- 
dium without dbcAMP. 
Double Immunofluorescent Staining of Nerve Fibers and Melanocytes 
in  Skin  and  Examination  by  Confocal Laser Scanning Microscopy. 
Fresh neonatal foreskin  fragments  were cut into small pieces; the 
specimens  were immersed in 4% (wt/vol) paraformaldehyde,  and 
2% (wt/vol) picric acid in 0.1  M  phosphate buffer (pH 7.4)  for 
24 h at 4~  then embedded in OCT compound. 10-20-btm cryo- 
sections  were then processed in  the following solutions:  (a)  l% 
(vol/vol) Triton X-100 (Sigma) for 40 rain; (b) mouse anti-TRP-1 
antibody  (MEL-5)  (1:200)  (Signet  Laboratories,  Inc.,  Dedbam, 
MA) in PBS for 1 h; (c) FITC-conjugated anti-mouse IgG anti- 
body (Sigma) (1:100) in PBS for l hr; (d) rabbit antineurofilament 
antibody (1:200)  (Sigma) in  PBS for 1 h;  (e) rhodamme-conju- 
gated anti-rabbit IgG antiserum  (1:100) in PBS for 1 h. The spec- 
imens were washed two  times  gently with  PBS  between  steps. 
Specimens  were then mounted with antifade  reagent (Molecular 
Probes,  Inc., Eugene, OR) for observation. 
Specimens  were analyzed with a Leica confocal laser scanning 
microscope (Leica,  Inc., Deerfield,  IL) equipped  with  an argon 
ion laser with an output power of 2-50 mW. The continuously 
variable detection pin hole was set at the minimal size for optimal 
signal  (37). The  specimens  were  scanned  first through  the  red 
channel (rhodamine)  to follow the course ofintraepidermal nerve 
fibers.  Then  the  same  field  of vision  was  scanned  through  the 
green channel  (fluorescein).  Finally,  images  of the two channels 
were superimposed to create  one image.  Each image of the opti- 
cal  section was  taken  at  0.5-1  p,m  intervals  in  the  512  ￿  512 
pixel format. 
Electron-Microscopic Observation.  Biopsy specimens obtained  from 
facial skin  of 25  donors were fixed  with  Trump's solution,  cut 
into several small pieces,  postfixed  in  1% osmium tetroxide, and 
embedded  in  epoxy resin.  Ultrathin  sections  were  made  on an 
Ultracut S (Reichert-Jung, Vienna, Austria) and placed  on Pelco 
i00 mesh grids (Ted Pella,  Inc., Redding,  CA) with (t.6% pilo- 
form (Ted Pella, Inc.) supporting films. The sections were stained 
with uranyl acetate and lead citrate, and examined in a transmission 
electron microscope (300; Philips, Holland).  Between 296 and 348 
sections  per donor were analyzed  for a total  of more than 8,000 
sections. At least 80 melanocytes were examined  in each specimen. 
1386  Innervation of  Melanocytes in Human Skin Figure 1.  Confocal laser scanning microscopy ofTRP-l-positive melanocytes  (green fluorescence) and neurofilament-positive  nerve fibers (red fluo- 
rescence) in human skin. (/t) Low magnification  of a representative  normal  skin cross-section, Melanocytes  (m) located in the epidermal basal layer are 
stained in green. A branching  axon stained in red is present in the dermal papilla (asterisk). Fine fibers with bead-like appearance (arrows)  arise from it and 
ascend toward one of the melanocytes. (B) Higher magnification of  the same field shown in (A). Orange color spots (arrowheads)  present at the lateral sides 
of the melanocyte (m) presumably represent sites ofaxon terminals attached to the melanocyte  cell body and are computer-generated when both fluores- 
cent wavelengths are perceived in the same pixel of the 512 ￿  512 grid. Fine filamentous  nerve fibers repeatedly entering and leaving the plane of sec- 
tion, are marked by arrows.  Bar, 50 lim. 
Cell Counts.  Equal numbers ofmelanocytes (5-8  ￿  10S/dish) 
were  plated  in  paired  35-mm  dishes  with  defined  melanocyte 
medium.  After overnight incubation culture  dishes were supple- 
mented with 10,  100, and 1,000 nM CGRP, SP, or VIP. In other 
experiments to compare the mitogenic effect of CGRP with the 
known  primary  melanocyte  mitogen  bFGF  (38),  cultures  were 
maintained in defined medium lacking cholera toxin in the pres- 
ence of 100  nM  CGRP  or 10 ng/ml bFGF shown  to be bFGF 
optimal dose (39,  40).  5 d later, cells were detached by incubation 
for 3-5  rain in 0.25% trypsin and cell number determined in an 
aliquot with a counter (Model ZM; Coulter Electronics Inc., Hi- 
aleah,  FL).  The number per dish is expressed as a percentage of 
the number seeded initially to accommodate the different seeding 
densities used among experiments. 
[3H]Thymidine Uptake.  Melanocytes  were  plated  in  24-well 
trays (Becton Dickinson and Co., Cockeysville, MD) at a density 
of 5-10  )<  104  cells /ml. After overnight incubation,  cells were 
stimulated with CGRP, SP, or VIP at a final concentration of 10- 
1,000  nM.  After 24-72  h  exposure  to  these  neuropeptides,  cells 
were labeled for 5 h  with  1.0 lICi/ml [3H]thymidine.  Cells were 
washed  three  times with  cold PBS,  lysed with 2  N  NaOH,  and 
then neutralized with the same volume of 2 N  HC1. Acid-insolu- 
ble materials were precipitated with 4 vol of 10% TCA, collected 
on  filters,  washed  three  times  with  10%  TCA  and  once  with 
100% ethanol,  and dried.  The radioactivity on the filters was de- 
termined using a liquid scintillation counter (Wallac  Inc.,  Gaith- 
ersburg, MD) (41). 
Tyrosinase Activity.  Tyrosinase activity was  measured accord- 
ing to  Park  et al.  (42).  In brief,  5  X  10 s cells were briefly soni- 
cated  in  80  mM PO4  2-,  pH  6.8,  containing  1%  Triton  X-100, 
and tyrosinase was extracted for 60 min at 4~  10-50  p,g ofcel- 
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lular  proteins  was  incubated  with  250  nM  L-tyrosine,  25  nM 
L-deoxyphenylalanine,  12.5  Jig  chloramphenicol,  and  5  p~Ci 
L-[3,5-3H]tyrosine  for  30-60  rain  at  37~  The  reaction  was 
stopped  by  addition  of 500  I.tl of 10%  TCA  containing  0.2% 
BSA.  TCA-soluble material  was  reacted  with  Norit A  (Sigma), 
and  released  3H20  was  measured  using  a  scintillation  counter. 
The activity was expressed as counts per minute 3H20 release per 
microgram protein per hour minus the nonspeciflc incorporation 
of radioactivity,  determined  by  using  lysate  boiled  for  30  rain 
(background).  Background was generally < 10% of the sample. 
Measurements" of lntracellular cAMP Accumulation.  1-2  ￿  106 
melanocytes suspended in 1 ml melanocyte growth medium were 
supplemented  with  10-1~  -6 M  CGRP.  The  cells were  pre- 
treated  with  or without  100  p,M  3-isobutyl-L-methyl-xanthine 
(IBMX), reported to enhance CGRP's effect on cAMP (43),  for 
24 h before the experiment. After 5 rain incubation at 37~  cells 
were spun clown and medium was replaced and resuspended with 
0.05 M  Tris-EDTA buffer/4 mM EDTA, pH 7.5.  Samples were 
then  boiled for 5  rain  and  centrifuged;  supernatants  were  mea- 
sured for cAMP content with a radioimmunoassay kit (Biomedi- 
cal Technologies Inc., Stoughton, MA). 
Results 
Confocal  Laser Scanning  Microscopic and Electron Microscopic 
Observations  of Melanocytes  and Nerve  Fibers in  Human  Skin. 
Double immunofluorescence  staining was  done  on normal 
human  skin using antibodies  to TRP-1  and neurofilaments 
to  identify  melanocytes  and  nerve  fibers,  respectively.  As 
expected,  melanocytes,  stained  with  green  fluorescence, Figure 2.  Melanocyte  innervation in skin. (A) An electron micrograph at a low magnification shows a nerve fiber (N) containing axons (arrows) cours- 
ing toward a melanocyte (M) at the dermo-epidermal  junction. (B) A step section of the same axon in A displayed in a higher magnification. The naked 
axon appears inside the melanocyte cytoplasm  (MC). The axons contain electron-dense synaptic vesicles of 120-15(/nm in diameter (arrowheads). K, kera- 
tinocyte; m, melanosome. Magnifications: (A) X6,800; (B) ￿  15,800. 
were  located in  the  basal layer at intervals  (Fig.  1).  Many 
transverse  or  longitudinal  profiles  of nerve  fibers  stained 
with red fluorescence in a beaded pattern were observed in 
the  dermal  papillae.  Some showed a Y-shaped bifurcation 
and  coursed  upward  to  the  epidermis  and  made  contact 
with one of the melanocytes in the basal layer. The contact 
site of nerve terminal and melanocyte was visualized as or- 
ange-yellow spots in the computer-generated color images 
when single-channel readings of green and red were super- 
imposed (Fig.  1). 
This  intimate  contact between  melanocytes  and  nerves 
was  confirmed by electron  microscopic  examination  (Fig. 
2-4),  Melanocytes were identified by the presence of mel- 
anosomes  in  varying stages  of maturity  in  the  cytoplasm, 
and by lack of tonofilaments  or desmosomes, well-known 
ultrastructural  features  of normal  melanocytes in  the  basal 
layer that permit them to be easily distinguished from kera- 
tinocytes (44). As well, profiles of nerve fibers in the super- 
ficial dermis were identified by their  characteristic  features 
of unmyelinated axonal complexes,  i.e.,  membrane-bound 
cylinders of electron-lucent cytoplasm with many microtu- 
bules  centrally,  corresponding to  axons,  enveloped by cell 
extensions of darker cytoplasm, corresponding to Schwann 
cell processes  (45).  The intraepidermal  nerve profiles were 
confirmed to be axons by seeking in consecutive sections a 
proximal  dermal  part  with  characteristics  of axonal  com- 
plexes as described above. Unexpectedly, many axonal pro- 
files  were encountered in the epidermis,  particularly in the 
basal  layer.  Occasionally,  axons  made  synapselike  close 
contact with the cell body of melanocytes in which plasma 
membranes  of the  axon  terminal  and  melanocyte  faced 
each  other  without  intervening  basal  lamina  (Fig.  4  C). 
1388  Innervation of Melanocytes in Human Skin Figure 3,  Contact between an epidermal melanocyte and an axon ter- 
minal. (A) A longitudinally sectioned axon (arrowheads) is situated directly 
beneath the melanocyte (M) and displays a broad attachment site with the 
melanocyte between positions A and B. (B) A higher magnification of the 
area between positions A  and B  shows that the axon terminal is in close 
contact with the melanocyte (M).  (C) A step section of A  shows that the 
distal part of the axon is capped by a Schwann cell sheath (arrows) and is in 
close apposition  to  the  melanocyte  (M).  (D)  A  naked  axon  containing 
many clear small synaptic vesicles (arrowheads) forms a close contact with 
a melanocyte (M)  that contains many stage IIl-IV melanosomes, m, mel- 
anosome. Magnifications:  (A)  X2,800;  (/3) X13,500;  (C)  XI1,500;  (D) 
X 14,500. 
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Furthermore,  some  axons  terminated  in  invaginations  in 
the melanocyte body (Fig.  4/3). The plasma membrane of 
such melanocytes adjacent to the axon terminal was slightly 
thickened, closely resembling postsynaptic membrane spe- 
cializations in nervous tissue  (Fig. 4 A). 
Effect of Neuropeptides on Melanocyte Proliferation.  Since  many 
intraepidermal nerve fibers are reported to contain several 
neuropeptides (reviewed in reference 16), including CGRP, 
SP, and VIP, and to modulate various skin functions through 
releasing these peptides (16),  we supplemented melanocyte 
cultures with neuropeptides to examine the possible func- 
tion of nerve-melanocyte interaction in skin. 
The effect of neuropeptides on melanocyte yield was de- 
termined at three different doses (10,  100, and 1,000 nM). 
SP  and  VIP  had  no  effect on  cell number in  any of the 
tested  doses.  After  5  d  of culture  in  melanocyte  growth 
medium in the presence of 100 nM of CGRP, SP, or VIP, 
melanocytes were  counted.  CGRP  consistently increased 
melanocyte cell number ~25% compared to control (Fig. 
5 A). Assuming that under our culture conditions melano- 
cyte  attachment  is  50%,  as  previously  determined  (46), 
control cells underwent 0.96 +  0.51 population doublings 
by day 5, while CGRP-treated cells underwent 1.43 +  0.58 
population doublings, a nearly 50% increase in actual growth 
rate, Modulation of cell number by SP and VIP was mini- 
mal in this experiment (Fig. 5 A). 
Because CGRP is reported to exert its effect by upregu- 
lating  intracellular  cAMP,  CGRP's  effect on  melanocyte 
proliferation was examined in cultures lacking cholera toxin, 
a known enhancer of cAMP levels in cells (47,  48). Dupli- 
cate cultures were stimulated with bFGF, to  compare the 
mitogenic effect of CGRP to that of an acknowledged ma- 
jor melanocyte mitogen (38).  Melanocyte yields increased 
within  5  d  by ~70%  in  the  presence  of CGRP  and  by 
~60% in the presence ofbFGF. 
Cell yields may be affected both by changes in mitotic 
rate and changes in survival rate, as illustrated for example 
by nerve growth factor, which appears primarily to modu- 
late the extent of apoptotic cell death in cultured neurons 
and melanocytes (49,  51).  To determine if CGRP stimu- 
lates  DNA  synthesis,  thymidine  incorporation  rate  was 
measured in melanocytes that were exposed to  100 nM of 
each of the three neuropeptides for 24 h  before the assay. 
Significant  increase  of thymidine  incorporation  was  ob- 
served in  cultures stimulated with CGRP,  roughly corre- 
sponding to the increase in cell yields (Fig.  6).  Neither SP 
nor VIP induced significant changes in thymidine incorpo- 
ration (Fig. 6). 
We further examined the  effect of CGRP  on melano- 
cyte DNA synthesis by examining its time course and con- 
centration dependence (Fig. 7). DNA synthesis was upreg- 
ulated  within  24  h  after  stimulation  by  CGRP  and  the 
increase was  sustained through 48 h  with a return toward 
baseline levels by 72 h after a single supplementation (Fig. 
7 A). CGRP induced statistically significant increases in DNA 
synthesis at 1-, 10-, and 100-nM concentrations (Fig. 7 B). 
Effect of Neuropeptides  on Melanogenesis.  One of the ma- 
jor functions of melanocytes is to synthesize melanin. Be- Figure  4.  Step  sections  of a 
single axon  innervating an  epi- 
dermal  melanocyte.  A  series  of 
step sections of a single axon ter- 
minal are shown in A-C.  (A)  A 
naked  nerve  axon  (N)  forms  a 
direct contact with a melanocyte 
(M).  The  lamina  densa  of the 
dermo-epidem'ual basement mem- 
brane,  which is clearly seen be- 
low  the  melanocyte  (arrows),  is 
absent  at  the  contact  site  be- 
tween  the  melanocyte  and  the 
axon.  (Inset) Higher  magnifica- 
tion shows the axon ternfinal in 
close apposition to  the  melano- 
cyte which is devoid of  basement 
membrane at the area  of contact 
with the axon. Note that, similar 
to  other  chemical  synapses  that 
are  known  to  transmit  signals 
from  a  neuron  to  its  target  cell 
(96),  the  presynaptic  ending  of 
the  axon  is  enlarged  to  form  a 
bouton.  Futhermore,  note  the 
thickening of the  plasma  mem- 
brane of the bouton  (arrow) and 
the  subplasmalemmal  specializa- 
tion of the target melanocyte (as- 
;erisk), two specialized structures 
reported to  be present in  neural 
synapses  (97).  (B) A  step section 
of the  same  axon  shown  in  A. 
Note that the axon ends in a nar- 
row  invaglnated  groove  m  the 
melanocyte (M).  (C)  In an addi- 
tional step section the axon  ter- 
minal  is  enveloped by  melano- 
cyte  cytoplasmic  projections 
(asterisks). Many clear vesicles  (ar- 
rows)  ranging  in  diameter  from 
140 to 220 nm are aggregating in the melanocyte cytoplasm at the apposition site.  As well, many synaptic vesicles  (arrowheads) of'~50 nm in diameter, 
presumptively of axonal origin, are present in the cytoplasm of the melanocyte and in the space between the mdanocyte and the nerve fiber. Magnifica- 
tions: (A)  ￿  11,600;  (inset) ￿  17,500;  (B) ￿  12,800;  (C)  ￿  17,000. 
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Figure 5.  Effects ofneuropeptides and bFGF on metanocyte proliferation. 
(A) Melanocyte cell yield was determined 5 d after supplementation with 
100 nM CGRP, SP, VIP, or diluent alone. Neuropeptide effect on cell 
number is expressed as percentage of cell yield for diluent-treated control 
cultures (100%).  Only CGRP supplementation showed statistically  sibmif- 
icant (*P <0.05,  nonpaired t test)  increases of melanocyte yield.  Graph 
represents mean +  SD of  three experiments, (B) Melanocytes were main- 
tained for 5  d  in medium lacking cholera toxin, in the presence of 100 
nM CGILP or diluent, or in the presence of both CG1LP  and  10 ng/nfi 
bFGF or diluent, bFGF increased melanocyte yield by ~60% and CGILP 
increased cell yield by ~70% above control (Contr,),  suggesting compara- 
cause  it  is  well-established  that  melanin  synthesis is largely 
regulated  by  tyrosinase,  the  rate-limiting  enzyme  of  the 
pathway  (52),  to  determine  ifneuropeptides  affect melano- 
genesis,  tyrosinase  activity  was  measured  72  h  after  expo- 
sure  to  100  nM  CG1KP,  VIP,  or  SP.  No  significant  effect 
was  seen for  any  of the  neuropeptides  examined  (data  not 
shown). 
Effect  of CGRP  on  Intracellular  Levels  qf cAMP,  Since  it 
was reported  in other cell types that  CGRP  mediates its bi- 
ological  actions via  cAMP-dependent  pathways  by  activat- 
ing  adenylate  cyclase  (34),  melanocytes  were  stimulated 
with  CGRP  and intracellular  cAMP  levels were  measured. 
As shown  in  Fig.  8,  CGRP  increased  cAMP  accumulation 
ble effects of CGIKP and bFGF on melanocyte proliferation under these 
culture conditions. CGIKP or bFGF effect on cell number is expressed as 
percentage of cell yield for control cultures (I00%). Cell yield of two dif- 
ferent culture dishes were averaged. 
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Figure  6.  Effect of neuropep- 
tides on DNA synthesis of mel- 
anocytes. 24 h  after exposure to 
100  nM  CGRP,  SP,  or  VIP,  .r 
melanocytes were  incubated with 
[3H]thymidine for 5  h.  Incorpo-  ~- 
i 
rated  [3H]thymidine  was  then 
counted.  Melanocytes  exposed  .~ 
to  CGRP  incorporated  ~'-'30% 
more  [3H]thymidine  than  dilu- 
ent-treated  controls  (*P  <0.05,  ~" 
nonpaired  t  test).  Graph  repre- 
sents mean -+ SD of two experi- 
ments. 
in melanocytes in a dose-dependent manner. The maximal 
cAMP  level,  induced  by  10  -s  M  CGRP,  was  approxi- 
mately twice the basal level. 
Discussion 
An interaction between epidermal melanocytes and the 
nervous  system  has  long  been  speculated  but  never  ac- 
cepted (1), despite one report of their physical proximity in 
murine skin (11).  Here we show an intimate physical con- 
nection ofintraepidermal axon terminals to melanocytes by 
immunohistochemical and electron microscopic means.  It 
is notable that the sites of contact between nerve axons and 
melanocytes are characterized by synapselike specialization, 
including thickening of pre- or postsynaptic plasma  mem- 
branes and submembraneous aggregation of vesicles,  similar 
to synaptic structures in nervous system. Because intraepi- 
dermal free nerve endings contain neuropeptides and pre- 
sumptively perform their afferent function through secre- 
tion of these neuropeptides (16), neuropeptides reported to 
be present in skin were examined in vitro for their effect 
on  melanocytes.  Of the  three  neuropeptides  examined, 
CGRP induced significant increases of DNA synthesis  rate 
and melanocyte number. The increased intracellular cAMP 
level in  melanocytes after exposure to  CGRP,  known  to 
mediate its effects through the cAMP pathway (34), further 
supports a direct action of CGRP  on melanocytes. Effects 
of substance  P,  VIP,  or  indeed  CGRP  on  melanocytes 
other than changes in growth rate and melanogenesis were 
not examined. 
Pigmentary  disorders  of skin  sometimes  cause  serious 
psychosocial  problems  for  patients  through  their  pro- 
nounced cosmetic disfigurement. Many are strongly associ- 
ated with neurologic abnormalities and/or manifest charac- 
teristic  dermatomal distribution patterns (53-57), suggesting 
regulation of melanocyte function by the nervous system. 
Although embryologic defects of the neural crest, the origin 
of both melanocytes and peripheral nerves, might account 
for pigmentary disorders in a dermatomal distribution pat- 
tern, much evidence suggests  that postdevelopmental neu- 
rologic abnormalities are also involved in the pathogenesis 
of  pigmentary disturbances. For example, in segmental viti- 
ligo, in which skin areas devoid of melanocytes occurs in a 
dermatornal  distribution,  degenerative  changes  in  nerves 
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Time- and dose-dependency of CGRP's effect on melano- 
cyte DNA synthesis. (A)  Melanocytes were  exposed up to  72 h  to  100 
nM CGRP and then were provided with [3H]thyrnidine. [3H]thymidine 
incorporation was determined as described in the legend to Fig. 6. Statis- 
tically significant increase  of [3H]thymidine uptake  was  observed at  24 
and 48 h  after CGRP supplementation (*P <0,05,  nonpaired t test).  (B) 
24 h  after exposure to increasing CGRP doses (10-t1-10 -v M)  [3H]thy- 
midine incorporation was measured in rnelanocytes. Cultures stimulated 
with  10-v-10  -v M  CGRP had significantly (*P <0.05, nonpaired t test) 
higher [3H]thymidine incorporation  than diluent  supplemented control 
cultures. Graph shows mean +- SD of two experiments. 
were reported  (58).  In  some  cases,  segmental vitiligo  ap- 
peared  on  neurologically  compromised  skin  (59)  after 
peripheral nerve injury (60) or in association with viral en- 
cephalitis (61). As well, leprosy, a mycobacterial disease pri- 
marily affecting the skin and peripheral nervous system, is 
often manifested by anesthetic hypomelanotic macules.  Elec- 
tron  microscopic  studies  of such  lesions  show  decreased 
numbers of epidermal melanocytes and degenerative changes 
of superficial nerve fibers (62).  In other disorders, both hy- 
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Figure 8.  Effect of increasing CGRP concentrations on cAMP level in 
melanocytes.  10  ~' melanocytes were  suspended in  1  ml  of melanocyte- 
defined medium and exposed to various concentrations of CGRP  for 5 
min. Cells were extracted, and cAMP level was measured as described in 
Materials and Methods. CGRP  increased intracellular cAMP in a  dose- 
dependent  manner with  maximal increase  of approximately  twice  the 
basal level with 10  u M  CGRP.  (*P <0.02, nonpaired t test.) 
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degenerative changes of dermal nerve fibers (6). 
Past  studies  of human  skin  have  reported  contact  be- 
tween the basal lamina of Schwann cells and the basal lam- 
ina ofmelanocytes (63,  64).  However, these contacts were 
found only in  skin  involved in  pigmentary disorders like 
vitiligo and incontinentia pigmenti achromians. One study 
of guinea pig's  skin  showed  direct contact between mel- 
anocytes and  nerve fibers and  the presence of specialized 
structures such as postsynaptic thickening of plasma mem- 
brane and vesicle aggregation  (11).  However, such obser- 
vations were never reported for human skin,  leading to a 
lack of appreciation of a physical interaction between neu- 
rons and melanocytes in humans. 
For  many  years  it  was  thought  that  cutaneous  nerves 
were restricted to  the  dermis,  but sophisticated immuno- 
histochemical studies  have revealed free nerve fibers even 
in the upper part of the epidermis (65, 66). Ample evidence 
suggests  that intraepidermal free nerves participate in  epi- 
dermal homeostasis as well as in the pathogenesis of certain 
skin diseases  through release of neuropeptides (67-69).  So 
far,  neuropeptides demonstrated in  the  epidermis  include 
SP  and  CGRP  (67).  In  addition  to  such  well-described 
functions of SP as vasodilation (70,  71), mast cell degranu- 
lation (72),  and immunomodulation (73),  SP has shown to 
be  mitogenic  for fibroblasts  and  epithelial  cells  (74,  75). 
Under  certain  circumstances,  SP  also  suppresses  kerati- 
nocyte growth (29).  CG1KP has a mitogenic effect on en- 
dothelial cells (76) and Schwann cells (77) as well as its va- 
sodilatory and immunomodulatory effects. In this study, we 
examined the melanocytic effect of these neuropeptides, as 
well as VIP,  a peptide widely distributed in dermis,  espe- 
cially around blood vessels  and  sweat glands  (78).  CGtKP 
consistently  induced  DNA  synthesis  and  increased  cell 
number. Although in an experimental medium containing 
cholera toxin the effect was less than that reported for the 
keratinocyte-derived melanocyte mitogens bFGF  (79,  80) 
and endothelin (81), in medium lacking cholera toxin their 
effect was  comparable. Cholera toxin is known to increase 
cAMP levels and to reduce the apparent effect in melano- 
cytes of agents such as cx-melanocyte-stimulating hormone 
(cx-MSH)  that  exert  their  effects  through  the  cAMP- 
dependent pathway (82).  This phenomenon is particularly 
interesting in the present case in that the biological actions 
of CGRP  in  several  cell  types  are  mediated  through  the 
cAMP  pathway  (83).  Rapid  accumulation  of intracellular 
cAMP in melanocytes after stimulation by CGRP is consis- 
tent with published data in other cell types (76, 77, 83); and 
the  more modest  increase measured  in  the  present  study 
(100% vs 400-600%) (83) is consistent with an artifactually 
increased basal level in those cultured human melanocytes. 
CGRP's effect on melanocyte proliferation is particularly 
interesting  in  light  of its  known  role  during  cutaneous 
wound  healing.  CGRP  and  other  neuropeptides  have  a 
trophic effect in regeneration of  UV-damaged skin (84). Thus, 
it is possible that neuropeptides play a role in melanocyte 
proliferation during cutaneous wound healing, as well. An- 
other possible function of neuropeptides is to induce mel- 
anocyte dendricity. Neuropeptides have been reported to 
translocate adhesion molecules like P- and E-selectin to the 
cell membrane (85) and to affect phosphorylation of the fo- 
cal  adhesion  protein  paxillin  (86).  Hence,  neuropeptides 
participate in the regulation of cell-substrate adhesion and 
ultimately  cell  motility  and  shape  (87).  Furthermore,  in 
neural crest-derived astrocytes,  neuropeptides regulate den- 
drite formation (88).  It is possible that neuropeptides may 
similarly affect melanocyte dendricity and/or their adhesion 
to the basement membrane or surrounding keratinocytes. 
Neuropeptides such as VIP have been reported to act as 
survival factors for certain neuronal populations  (88,  89). 
Therefore, they may act as  survival factors for cutaneous 
melanocytes.  Interestingly,  one  neuropeptide,  neuropep- 
tide  Y,  was  reported to  regulate  the  secretory activity of 
melanin-containing cells in Xenopus laeuis (90). It is possible 
that in cutaneous melanocytes neuropeptides may not reg- 
ulate melanin synthesis  per se but may affect melanosomal 
transfer to surrounding keratinocytes. 
Finally,  neuropeptides play an important role in regulat- 
ing  the  synthesis  and  secretion  of immune  cytokines in- 
cluding IL-1, IL-2, IL-4, IL-6, and TNF-c~ (91-93). Mel- 
anocytes  are  known  to  express  a  variety  of  cytokines 
including, IL-1, IL-6, IL-8, and TNF-ot (94). Furthermore, 
melanocytes are  capable of phagocytosing antigens  and  as 
such are speculated to function as accessory immune cells 
within the skin (95). It is tempting to speculate that cutane- 
ous neuropeptides may modulate melanocyte immune func- 
tion, particularly during cutaneous inflammation. 
In  summary,  this  paper  expands  an  earlier  study  and 
demonstrates  that  in  human  skin  there  are  intimate  syn- 
apselike  connections  of  axon  terminals  to  melanocytes. 
CGla.P,  one  of the  neuropeptides  present  in  epidermal 
nerve endings,  induces melanocyte proliferation. These data 
expand  our understanding  of normal  and  disordered  epi- 
dermal pigmentation and the complex relationship of mel- 
anocytes to their epidermal environment. 
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